35
THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

Embed Size (px)

Citation preview

Page 1: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

THORACIC AORTIC PATHOLOGY

CHALLENGES AND SOLUTIONS

Thomas C. Naslund, M.D.Vanderbilt University Medical Center

Page 2: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

CONFLICT OF INTEREST

WL Gore Investigator, Speaker, Consultant

Boston Scientific Consultant

LeMaitre VascularScientific Advisory Board

Page 3: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

OFF LABEL USE

• WL Gore TAG

• Cook Zenith

• WL Gore Excluder

Page 4: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

FREQUENTLY SEEN PATHOLOGY

• Aneurysm

-fusiform *

-saccular (concern for infection)

• Aortic Dissection – Type A* and B

• Traumatic transection

• Penetrating ulcer

• Intramural hematoma

*labeled use for TAG

*surgical management

Page 5: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center
Page 6: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

PENETRATING ULCER

Page 7: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

INTRAMURAL HEMATOMA

Page 8: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

THORACIC AORTIC ANEURYSM

• Atherosclerosis of iliacs– 8-9 mm EI make most TEVAR easy

– 7-8 mm EI make some TEVAR difficult

– <6 mm EI is a clear danger zone (alternate access)• Dilation with serial dilators if EI normal

• KY jelly helps

• Extreme caution with dilators and atherosclerosis

• Tortuosity of iliacs and TA (arch)• Neck

– <2cm in straight distal attachment can work

– 2cm with angle in arch will not work

Page 9: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

ACCESS FOR THE DISEASED ILIAC

• Conduit– Sutured to the CI artery end to side– Complete TEVAR via conduit– Consider anastomosis to CFA after completion

• May need secondary intervention• CFA may already be exposed/opened/damaged

• Direct CI/Abdominal Aorta Access– Transverse incision over rectus sheath– Retract rectus laterally/RP dissection– CI/terminal aorta easily exposed – Counter puncture in lower quadrant– Direct arterial closure

Page 10: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

GOALS OF ENDOVASCULAR MANAGEMENT

Acute Type B Aortic Dissection

• Redirect flow into true lumen

• Cover entire descending thoracic aorta

• Provide satisfactory visceral flow

• Facilitate aortic healing

• Avoid surgical repair

Page 11: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

DISSECTION TREATMENT ALGORITHM

• Type A- Medical Therapy &Emergency Cardiac Surgery Evaluation

• Type B- Medical therapy» Stent graft for complications in acute phase» Stent graft for aneurysm formation in late follow up» Long term follow up for all Type B to assess aneurysm

formation/stent graft

Page 12: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

NECK PROBLEMS/SOLUTIONS

• Big (>36mm) – 45mm TAG in EU

• Small (<23mm)– 18-23mm diameter graft

• Short (< 2cm)– Debranching/fenestration

• Angled (>?)– Specific design/fenestration

Page 13: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

LENGTHENING THE NECKCovering Branch Vessels

• Left Subclavian– Consider vertebrobasilar circulation

• Contralateral vertebral/carotid disease

• Celiac– Consider pancreaticoduodenal and gastroduodenal

• SMA disease

• Coiling typically not needed– Subclavian for Type II leak

• Transbrachial– Celiac

• Flow robust– Catheterize, cover celiac/trap catheter, coil

Page 14: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center
Page 15: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

SURGICAL DEBRANCHING

• Viscerals– Celiotomy

• Midline gets all 4

• Left flank gets 3,maybe 4

• Arch– Left subclavian to carotid transposition– Carotid-carotid bypass (retroesophageal)– Aortoinnominant & carotid bypass

Page 16: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center
Page 17: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

ARCH REPAIR

Page 18: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

TRAUMATIC TRANSECTION

• Deceleration injury–MVA

–falls

• Sudden movement of aortic arch

• Circumferential tear of arterial intima and media

• Survivors have intact adventitia and possibly some media

Page 19: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

TRAUMATIC TRANSECTION

• Innominate artery second most common site

Page 20: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

VANDERBILT SERIESOpen Repair 1987

• 41 Patients

• 5 Died without repair– 3 preoperatively

– 2 en route with emergency thoracotomy

• 5/36 Repaired died during operation– 3/5 associated with aortic clamping

• 2/36 Paraparesis

Page 21: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

TRANSECTION PRE OP MEDICAL MANAGEMENT

• Beta Blockade

• BP/HR control

• Discontinue after repair

Page 22: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

STENT GRAFT REPAIR OF TRAUMATIC TRANSECTION

n = 20

• Since 2005

• Age 35 (15 – 72)

• Mortality 1/20 (5%) – 72 yo MSOF

Page 23: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

STENT GRAFT REPAIR OF TRAUMATIC TRANSECTION

n = 20• Mean procedure time 103min

• Mean blood loss 390ml

• Mean intraoperative transfusion 1 unit

• Grafts utilized– TAG - 9

– Cook Iliac extenders- 9

– Excluder aortic cuffs - 2

Page 24: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

STENT GRAFT REPAIR OF TRAUMATIC TRANSECTION

n = 20

• Technical success 100%– graft exclusion of injured

segment

– No deaths pre operatively

• Operative complications– groin access site – 2

– TAG graft collapse – 2

– spinal cord injury – 0

– dialysis – 0

Page 25: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

LATE FOLLOW UP

• Erosions – 0

• Endoleaks/aneurysm – 0

• Access site false aneurysm – 0

• Paraplegia – 0

• Secondary interventions – 0

Page 26: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

USE OF COOK ILIAC LIMB EXTENDER

• Aorta diameter too small for TAG prosthesis (<23mm)

• 55 mm length (satisfactorily covers entire area of injury)

• Z stent design (no collapse)

• Requires manual loading into long sheath to reach aortic arch

Page 27: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center
Page 28: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

ZENITH Delivery and Deployment

Page 29: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center
Page 30: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

USE OF ABDOMINAL AORTIC CUFF EXTENDERS

• 33 – 36 mm length

• Reported in several series with success

• Requires 3 or more individual cuffs to bridge injured region

• Requires inventory of substantial numbers of aortic cuffs

• Cook, Medtronic, and Gore

Page 31: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

TIGHT ARCH

• Typical of adolescence and young adults

• Implant can either poorly oppose the inner arch and collapse

Page 32: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center
Page 33: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

FOLLOW UP

• Interval CT in 1 – 3 days (renal function considerations)

• Follow up CT 1 -3 months after discharge

• Annual CT • Eventually CT each 3-5

years • Emphasis on permanent

life-long follow up

Page 34: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

LATE CONCERNS

• Erosion

• False aneurysm formation

• Infections

Page 35: THORACIC AORTIC PATHOLOGY CHALLENGES AND SOLUTIONS Thomas C. Naslund, M.D. Vanderbilt University Medical Center

MINIMAL AORTIC INJURY

• Focal-non-circumferential intimal disruption

• No false aneurysm

• No periaortic hematoma

• Suitable for medical therapy and CT follow up rather than intervention– Healing typical in 3-6 months– Persistent fixed lesions identified after 1 year

followup